Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma

References

• Snow H. Melanotic cancerous disease. Lancet2, 872 (1892).
   Google Scholar
• Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann. Surg.193(3), 377–388 (1981).
   PubMed Web of Science ®Google Scholar
• Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional lymph nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann. Surg.214(4), 491–501 (1991).
   PubMed Web of Science ®Google Scholar
• McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg. Gynecol. Obstet.161(6), 575–580 (1985).
   PubMedGoogle Scholar
• Reintgen DS, Cox EB, McCarty KS Jr, Vollmer RT, Seigler HF. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann. Surg.198(3), 379–385 (1983).
   PubMed Web of Science ®Google Scholar
• Roses DF, Provet JA, Harris MN, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann. Surg.201(1), 103–107 (1985).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery86(2), 343–351 (1979).
   PubMed Web of Science ®Google Scholar
• Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J. Clin. Oncol.6(1), 163–172 (1988).
   PubMed Web of Science ®Google Scholar
• Milton GW, Shawn HM, McCarthy WH, Pearson L, Balch CM, Soong SJ. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br. J. Surg.69(2), 108–111 (1982).
   PubMed Web of Science ®Google Scholar
• Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routinely elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer41(3), 948–956 (1978).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Adamus J, Bandiera DC et al. Inefficacy of immediate lymph node dissection in stage I melanoma of the limbs. N. Engl. J. Med.297(12), 627–630 (1977).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Adamus J. Bandiera DC et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer49(11), 2420–2430 (1982).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanoma for patients 60 years of age and younger. Ann. Surg.224(3), 255–266 (1996).
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg.127(4), 392–399 (1992).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J. Surg.16(2), 214–221 (1992).
   PubMed Web of Science ®Google Scholar
• Moroi Y. Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. Int. J. Clin. Oncol.6, 485–489 (2009).
   Google Scholar
• Chakera AH, Hesse B, Burak Z et al. EANM–EORTC general recommendations for sentinel node diagnostics in melanoma. Eur. J. Nucl. Med. Mol. Imaging36(10), 1713–1742 (2009).
   PubMed Web of Science ®Google Scholar
• Stadelman WK. The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma. Clin. Plast. Surg.37(1), 79–99 (2010).
   PubMedGoogle Scholar
• Andtbacka RH, Gershenwald JE. Role of sentinel node biopsy in patients with thin melanoma. J. Natl Compr. Canc. Netw.7(3), 308–317 (2009).
   PubMed Web of Science ®Google Scholar
• Wright BE, Scheri RP, Ye X et al. Importance of sentinel lymph node biopsy with thin melanoma Arch. Surg.143(9), 892–899 (2008).
   PubMedGoogle Scholar
• Murali R, Sherman RN, Thompson JF et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid (so-called atypical spitzoid tumors). Ann. Surg. Oncol.15(1), 302–309 (2008).
   PubMed Web of Science ®Google Scholar
• Robinson DS, Sample WF, Fee HJ, Holmes C, Morton DL. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloid gold scanning. Surg. Forum28, 147–148 (1977).
   PubMedGoogle Scholar
• Yee VS, Thompson JF, McKinnon JG et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann. Surg. Oncol.12, 429–439 (2005).
   PubMed Web of Science ®Google Scholar
• Noweki ZI, Rutowski P. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institutions experience. Melanoma Res.13, 35–43 (2003).
   PubMedGoogle Scholar
• Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J. Nucl. Med.39(7), 1185–1190 (1998).
   PubMed Web of Science ®Google Scholar
• Essner R. Defining the highway of lymphatic patterns for melanoma. Lancet Oncol.8(9), 755–757 (2007).
   PubMedGoogle Scholar
• Essner R, Bostick PJ, Glass ECet al. Standardized probe-directed sentinel node sentinel node dissection in melanoma. Surgery127(1), 26–31 (2000).
   PubMed Web of Science ®Google Scholar
• Haigh PI, Glass EC, Essner R. Accuracy of γ probes localizing radioactivity: in-vitro assessment and clinical complications. Cancer Biother. Radiopharm.15(6), 56–59 (2000).
   Google Scholar
• Villa G, Agnese G, Bianchi P et al. Mapping the sentinel lymph node in malignant melanoma by blue dye, lymphoscintigraphy and intraoperative γ probe. Tumori86(4), 343–345 (2000).
   PubMedGoogle Scholar
• Essner R, Bostick PJ, Glass ECet al. Standardized probe-directed sentinel node sentinel node dissection in melanoma. Surgery127(1), 26–31 (2000).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am. J. Surg. Pathol.12(8), 612–618 (1998).
   Google Scholar
• Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination for sentinel nodes from melanoma patients. Semin. Diag. Pathol.25(2), 100–111 (2008).
   PubMedGoogle Scholar
• Alkhatib W, Hertzenburg C, Jewel W, Al-Kasspooles MF, Damjanov I, Cohen MS. Utility of frozen section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision makings. Am. J. Surg.196, 827–832 (2008).
   PubMedGoogle Scholar
• Aryian S, Aryian C, Farber LR, Fischer DS, Flynn SD, Truini C, Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J. Am. Coll. Surg.198, 924–932 (2004).
   PubMedGoogle Scholar
• National Comprehensive Cancer Network Practice Guidelines in Oncology. Practice Guidelines in Melanoma 2, (2010).
   Google Scholar
• Carson KF, Wen DR, Li PX et al. Nodal nevi and cutaneous melanomas. Am. J. Surg. Pathol.20(7), 834–840 (1996).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Herschmann HR, Gaynor RB. Detection of S-100 protein as an aid to identification of melanocytic tumors. Int. J. Cancer30(3), 295–297 (1982).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Bailly C, Paul E, Remotti F. Melanocytic Tumors: a Guide to Diagnosis. Lippincott-Raven, PA, USA (1997).
   Google Scholar
• Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts non-sentinel lymph node involvement. J. Clin. Oncol.22, 3345–3349 (2004).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Huang RR et al. Prediction of metastatic melanoma in non-sentinel nodes and clinical outcome based on the primary melanoma and sentinel node. Mod. Pathol.17, 747–755 (2004).
   PubMed Web of Science ®Google Scholar
• Murali R, Cochran AJ, Cook MG et al. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer115(2), 5026–5037 (2009).
   PubMedGoogle Scholar
• Cho MG, Badenay C, Malvehy J et al. Prognostic value of tyrosinase reverse transcriptase per analysis in melanoma sentinel lymph nodes: long term followup analysis. Clin. Exp. Derm.34(8), 863–869 (2009).
   PubMedGoogle Scholar
• Abrahamsen HN, Sorrensen BS, Nexo E et al. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA. Clin. Can. Res.11(4), 1425–1433 (2005).
   PubMedGoogle Scholar
• Hilari JM, Mangas C, Xi L et al. Molecular staging of pathologically negative lymph nodes from melanoma patients using multi-marker, quantitative real-time PCR. Ann. Surg. Oncol.16(1), 177–185 (2009).
   PubMedGoogle Scholar
• Kuhl SS, Opel MC, Wei JP. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed paraffin-embedded tissue. Mol. Pathol.22(4), 538–546 (2009).
   Google Scholar
• McMasters KM, Noyes RD, Reintgen DS et al. Lessons learned from the Sunbelt Melanoma Trial. J. Surg. Oncol.86, 212–223 (2004).
   PubMed Web of Science ®Google Scholar
• Morton DL, Thompson JF, Cochran AJ et al. Sentinel node biopsy or nodal observation in melanoma. N. Engl. J. Med.358(25), 2698–2703 (2006).
   Google Scholar
• Wong SL, Morton DL, Thompson JF et al. Melanoma patients with positive sentinel lymph nodes who did not undergo completion completion lymphadenectomy: a multiple centerstudy. Ann. Surg. Oncol.6, 809–816 (2006).
   Google Scholar
• Shivers SC, Wang X, Li W et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA280(16), 1410–1415 (1998).
   PubMed Web of Science ®Google Scholar
• Thomas JM, Ptocskai EJ. The argument against sentinel node biopsy for malignant melanoma. BMJ321, 3–4 (2000).
   PubMedGoogle Scholar